Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 15,636 shares at $19.78 ($309K) on 2024-01-09, disclosed to the SEC on 2024-01-11.
Seasonal sale ($309k) by President and CEO — this insider has traded DNLI in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.78 | 7,818 | $155K | 50.0% |
| 2 | $19.78 | 7,818 | $155K | 50.0% |
| Total | $19.78 avg | 15,636 | $309K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |